Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium

Cat. No.: HY-W013175S2: FAQs
Data Sheet Handling Instructions

Molarity Calculator

Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ (disodium) is the ¹³C and ¹⁵N labeled Uridine 5'-monophosphate disodium salt[1]. Uridine 5'-monophosphate disodium salt is component used for RNA synthesis[2].

For research use only. We do not sell to patients.

Uridine 5'-monophosphate-<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>2</sub> disodium Chemical Structure

Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium Chemical Structure

Size		Stock
50 mg		Get quote
100 mg		Get quote
250 mg		Get quote
Other size		Get quote

Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium:

Uridine 5'-monophosphate disodium salt In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ (disodium) is the ¹³C and ¹⁵N labeled Uridine 5'-monophosphate disodium salt[1]. Uridine 5'-monophosphate disodium salt is component used for RNA synthesis[2].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Uridine 5'-monophosphate-¹³C₉,¹⁵N₂ disodium Related Antibodies
Molecular Weight	379.07
Formula	¹³C₉H₁₁¹⁵N₂Na₂O₉P
SMILES	O=[13C]([13CH]=[13CH][15N]1[13C@@]2([H])[13C@@]([13C@@]([13C@](O2)([13CH2]OP(O[Na])(O[Na])=O)[H])(O)[H])(O)[H])[15NH][13C]1=O
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation	Data Sheet (273 KB) Handling Instructions (2659 KB)
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief] [2]. Hozumi Y, et al. Orotate phosphoribosyltransferase localizes to the Golgi complex and its expression levels affect the sensitivity to anti-cancer drug 5-fluorouracil. Biomed Res. 2015;36(6):403-9. [Content Brief]